FWP
NASDAQ:FWP
Forward Pharma A/S
- Stock
Last Close
1.95
27/12 21:00
Volume Today
43.35K
Avg: 9.84K
PE Ratio
151.31
PFCF: -
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -15.70M - | -19.02M 21.15% | -37.00M 94.59% | -33.34M 9.91% | 917.09M 2,851.06% | -8.72M 100.95% | -4.22M 51.61% | -6.45M 52.78% | -1.89M 70.66% | |
depreciation and amortization | 4K - | 3K 25% | 37K 1,133.33% | 109K 194.59% | 227K 108.26% | 4K 98.24% | 1K 75% | |||
deferred income tax | 466K - | 291K 37.55% | -255.45M 87,884.54% | |||||||
stock based compensation | 579K - | 5.95M 927.81% | 13.54M 127.54% | 14.29M 5.52% | 7.08M 50.43% | 6.17M 12.88% | 2.15M 65.24% | 334K 84.43% | 1K 99.70% | |
change in working capital | 76K - | 844K 1,010.53% | -910K 207.82% | 5.73M 729.23% | -1.19M 120.70% | -5.42M 357.72% | -89K 98.36% | 402K 551.69% | -658K 263.68% | |
accounts receivables | ||||||||||
inventory | ||||||||||
accounts payables | 446K - | 2.08M 367.04% | 3.93M 88.72% | 4.20M 6.84% | -1.26M 129.90% | -5.81M 362.42% | ||||
other working capital | -370K - | -1.24M 234.86% | -4.84M 290.72% | 1.53M 131.52% | 71K 95.35% | 384K 440.85% | ||||
other non cash items | 6.66M - | 2.76M 58.61% | -11.26M 508.16% | -21.18M 88.18% | 272.18M 1,384.91% | -6.82M 102.50% | -67K 99.02% | 190K - | ||
net cash provided by operating activities | -8.37M - | -9.46M 12.98% | -35.13M 271.32% | -34.10M 2.91% | 939.95M 2,856.04% | -14.79M 101.57% | -2.23M 84.91% | -5.71M 156.07% | -2.36M 58.71% | |
investments in property plant and equipment | -6K - | -382K 6,266.67% | -31K 91.88% | -3K 90.32% | ||||||
acquisitions net | ||||||||||
purchases of investments | -191.11M - | |||||||||
sales maturities of investments | 43.41M - | 41.20M 5.09% | 85.37M 107.20% | |||||||
other investing activites | -5K - | 3K - | -1K - | |||||||
net cash used for investing activites | -191.12M - | 43.03M 122.51% | 41.17M 4.32% | 85.36M 107.35% | 3K 100.00% | -1K - | ||||
debt repayment | ||||||||||
common stock issued | 7.95M - | 220.72M 2,675.98% | 155K 99.93% | 114K 26.45% | 49K 57.02% | 1K 97.96% | 2K - | 3K 50% | ||
common stock repurchased | ||||||||||
dividends paid | -1.09B - | |||||||||
other financing activites | 2.45M - | 16.85M 589.00% | -24.81M - | -8.12M 67.27% | -799K 90.16% | -285K 64.33% | ||||
net cash used provided by financing activities | 10.40M - | 237.57M 2,185.00% | 155K 99.93% | 114K 26.45% | -1.12B 981,407.89% | -8.12M 99.27% | -799K 90.16% | -283K 64.58% | 3K 101.06% | |
effect of forex changes on cash | 103K - | 5.40M 5,146.60% | -1.14M 121.06% | -1.55M 36.20% | 145.03M 9,457.10% | -4.11M 102.83% | -1.91M 53.41% | 7.49M 491.12% | -5.96M 179.63% | |
net change in cash | 2.13M - | 42.39M 1,893.14% | 6.92M 83.68% | 5.63M 18.66% | 51.66M 817.68% | -27.01M 152.29% | -4.94M 81.70% | 1.49M 130.12% | -8.32M 658.56% | |
cash at beginning of period | 828K - | 2.96M 256.88% | 45.35M 1,434.65% | 52.27M 15.26% | 57.90M 10.77% | 109.55M 89.22% | 82.54M 24.66% | 77.60M 5.99% | 79.09M 1.92% | |
cash at end of period | 2.96M - | 45.35M 1,434.65% | 52.27M 15.26% | 57.90M 10.77% | 109.55M 89.22% | 82.54M 24.66% | 77.60M 5.99% | 79.09M 1.92% | 70.77M 10.52% | |
operating cash flow | -8.37M - | -9.46M 12.98% | -35.13M 271.32% | -34.10M 2.91% | 939.95M 2,856.04% | -14.79M 101.57% | -2.23M 84.91% | -5.71M 156.07% | -2.36M 58.71% | |
capital expenditure | -6K - | -382K 6,266.67% | -31K 91.88% | -3K 90.32% | ||||||
free cash flow | -8.37M - | -9.47M 13.05% | -35.51M 275.12% | -34.14M 3.87% | 939.94M 2,853.53% | -14.79M 101.57% | -2.23M 84.91% | -5.71M 156.07% | -2.36M 58.71% |
All numbers in USD (except ratios and percentages)